Forbion Growth Opportunities Fund III Cooperatief U.A.
10% Owner
- 2026
- Aug 7, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Forbion Growth Opportunities Fund III Cooperatief U.A. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Erez Chimovits - $34.92M in BRVE purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $34.92M in BRVE purchases and sales in the last 12 months
- AH Bio Fund IV, L.P. - $19.80M in BRVE purchases and sales in the last 12 months
- Christopher Viehbacher - $1.50M in BRVE purchases and sales in the last 12 months
- Travis Murdoch - $1.50M in BRVE purchases and sales in the last 12 months
- David Charles Lubner - $1000K in BRVE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Forbion Growth Opportunities Fund III Cooperatief U.A.?
Forbion Growth Opportunities Fund III Cooperatief U.A. is an investment firm, tracked as 10% Owner of Braveheart Bio, Inc. (BRVE). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Forbion Growth Opportunities Fund III Cooperatief U.A. submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Forbion Growth Opportunities Fund III Cooperatief U.A. been buying or selling stock?
Recorded transactions: 2 open-market purchases ($64.80M) and 0 open-market sales across all tracked filings.
